Background: Low glomerular filtration rate (GFR) is associated with a worse outcome after coronary revascularization. Recently, a new specific equation to calculate the estimated GFR (eGFR) in Japanese populations has been reported, and it might be more accurate than the previously used equations. However, the relationship between a low GFR defined using the new equation for the Japanese population and the incidence of stroke following complete coronary revascularization is not yet known.
t is well known that patients with end-stage renal disease, such as those on dialysis, are at significantly high risk for cardiovascular morbidity and mortality. 1 Furthermore, patients with less severe impairment of kidney function who are not on dialysis are also at increased cardiovascular risk compared with those with preserved kidney function. [2] [3] [4] [5] This suggests that moderate impairment of kidney function has an impact on cardiovascular morbidity and mortality. Therefore, chronic kidney disease (CKD) has been defined as either the presence of a low glomerular filtration rate (GFR) (ie, GFR <60 ml · min -1 · 1.73 m -2 ) or the presence of kidney damage, regardless of the cause, for a period of 3 months or more. 6 The GFR can be estimated using either the following 4 variables: age, gender, ethnicity (Black people or White people) and serum creatinine (sCr) levels, or by the simplified Modification of Diet in Renal Disease (MDRD) study equation (MDRD equation). 6-8 However, it has been reported that this equation is less accurate for the Asian population and is biased towards estimated GFR (eGFR) values <60 ml · min -1 · 1.73 m -2 . 8-11 Therefore, a modified MDRD equation has been proposed for the Chinese and Japanese populations that uses a separate correlation coefficient. More recently, a novel equation has been reported that might estimate the GFR in Japanese populations more accurately than the previous modified MDRD equation. 12 There are many studies that demonstrated the significance of mild to moderate renal dysfunction in cardiovascular morbidity and mortality. However, most of these used definitions that were based on creatinine clearance or the GFR estimated by either the MDRD equation or the previous modified MDRD equation. In addition, these studies were Low GFR and Stroke mainly conducted on Western populations. Therefore, the significance of a low GFR estimated using a specific equation for the Asian population remains unclear.
Recently, the focus has been on mild to moderate renal dysfunction as an important public health problem, not only for the primary prevention of coronary artery disease (CAD) 13, 14 but also for the secondary prevention of CAD. [15] [16] [17] [18] [19] [20] [21] [22] From the perspective of secondary CAD prevention, coronary revascularization, especially complete revascularization, has been shown to be beneficial for the prevention of recurrent coronary events. 23, 24 As CAD events might be prevented or delayed by complete coronary revascularization, in the clinical care of patients following complete coronary revascularization, physicians should pay close attention to the incidence of other cardiovascular diseases including stroke, rather than solely the recurrence of CAD.
Furthermore, the frequency of stroke in the Asian population is greater than in the Western population, 25 and stroke mortality in the Asian population is 3-fold higher than in the Western population. 26 Therefore, stroke prevention is a very important issue for Asian patients who have undergone complete coronary revascularization. To date, the low GFR in stroke incidence during long-term follow up (≥10 years) among patients who have undergone complete coronary revascularization has not been determined.
The aim of the present study was to assess the relationship between a low GFR defined as eGFR <60 ml · min -1 · 1.73 m -2 using the Japanese equation, and the incidence of fatal and non-fatal stroke in a cohort of patients with severe CAD following complete coronary revascularization.
Methods

Patients and Data Collection
Data from consecutive patients who had undergone coronary revascularization, including percutaneous coronary intervention (PCI) and coronary artery bypass surgery (CABG), at Juntendo University Hospital (Tokyo, Japan) between January 1984 and December 1992 were analyzed. Patients who had achieved complete revascularization, that is, no unbypassed major vessels had a stenosis ≥50%, were enrolled. 23, 24 Patients with an untreated neoplasm at baseline and those with associated complex cardiac procedures, such as valve replacement or aneurysm repair at the time of surgical revascularization, as well as non-Japanese patients, were excluded. To identify the mortality risk associated with an eGFR independent of dialysis, patients on dialysis were excluded.
Demographic data including age, gender, body mass index (BMI), coronary risk factors, medication use, revascularization procedure-related factors and comorbidities were collected using our institutional database. Estimated GFR was obtained by using the following equation specifically for Japanese patients: GFR=194×(sCr) -1.094 ×(Age) -0.287 (×0.739 if female). 12 In the present study, a low GFR was defined as an eGFR <60 ml · min -1 · 1.73 m -2 . This value is the generally accepted cut-off value for CKD and corresponds to CKD stages 3, 4, and 5, according to the National Kidney Foundation practice guidelines. 27 Patients with an eGFR ≥60 ml · min -1 · 1.73 m -2 were not placed in a no CKD group, because it might include some patients that have had chronic kidney damage for a period of 3 months or more, despite a higher eGFR. Therefore, patients were categorized in the preserved GFR group, which included patients with an eGFR ≥60 ml · min -1 · 1.73 m -2 , or the low GFR group, which included patients with eGFR <60 ml · min -1 · 1.73 m -2 . Hypertension was defined as a systolic blood pressure ≥140 mmHg, a diastolic blood pressure ≥90 mmHg, or treatment with antihypertensive medications. Diabetes mellitus (DM) was defined as a fasting plasma glucose level ≥126 mg/dl or treatment with oral hypoglycemic drugs or insulin injections. A current smoker was defined as one who smoked at the time of complete revascularization or who had quit smoking within 1 year before complete revascularization. Patients with isolated PCI were those in whom complete revascularization was achieved by PCI without the need for any bypass grafting.
The follow-up period ended on September 30, 2000. Survival data and data on the incidence of stroke were collected by serial contact with the patients or their families, and were assessed from the medical records of patients who had died and of those who were followed up at our hospital. Information about the circumstances and date of death was obtained from the families of patients who died at home, and details of the events or the cause of death was supplied by other hospitals or clinics where the patients had been admitted. All data were collected by blinded investigators. Stroke was defined by the World Health Organization (WHO) criteria: a focal neurological disorder with rapid onset that persists for at least 24 h or until death, which includes ischemic stroke and hemorrhagic stroke (intracerebral hemorrhage and subarachnoid hemorrhage) and excluding transient ischemic attack (defined as focal neurological symptoms lasting less than 24 h), subdural hemorrhage, epidural hemorrhage, poisoning, and symptoms caused by trauma. 28 The stroke diagnoses were verified by neurologists. In this analysis, the clinical outcome was a composite incidence of fatal and non-fatal stroke.
The present study was approved by the internal review board of this institute, and was performed according to the principles expressed in the Declaration of Helsinki and the ethics policy of this institute.
Statistical Analysis
Continuous variables are expressed as the mean (standard deviation). Normally distributed variables were compared using Student's t-test, and the Mann-Whitney U-test was used for non-normally distributed variables. Categorical data were tabulated as frequencies and ratios, and were compared using the chi-square test or the Fisher exact test.
Survival was compared between patients in the low GFR group and in the preserved GFR group using the KaplanMeier estimate with the log-rank test. Hazard ratios (HR) of the low GFR group were calculated using the Cox proportional hazards model. The assumption of proportional hazards was assessed using a log-minus-log survival plot. Univariable analysis was based on the proportional hazard model to determine the association between stroke incidence and the following variables: age, gender, BMI, current smoker, DM, hypertension, systolic and diastolic blood pressure, total and HDL cholesterol, triglyceride, hemoglobin, sCr, atrial fibrillation, prior MI, prior stroke, left ventricular ejection fraction (LVEF), number of diseased vessels, presence of a LMT lesion, presence of an arterial bypass graft to the left anterior descending (LAD) artery, whether complete revascularization was achieved by isolated PCI, use of drugs, and the low GFR group or the preserved GFR group. Variables regarded as significant (ie, P≤0.10) were included in the multivariable analysis. Multivariable analyses verified the interactions between each variable.
A P-value of <0.05 was considered statistically significant, unless otherwise indicated. All data were analyzed using SPSS version 11.0 for Windows (SPSS Inc, Chicago, IL, USA). KONISHI H et al.
Results
Characteristics of Patients
During the study period, complete revascularization was achieved in 1,809 patients. Among them, 321 patients (17.8%) had a low GFR. Baseline and clinical data for all patients were fully documented during the follow-up period (mean 11.4 [2.9] years) (Tables 1,2) . Patients in the low GFR group were significantly older and more likely to be male than patients in the preserved GFR group. Compared with patients in the preserved GFR group, those in the low GFR group had higher serum triglyceride levels, higher systolic blood pressure levels and a greater number of diseased vessels. They also had lower hemoglobin levels and more impaired left ventricular function than those in the preserved GFR group.
Higher percentages of patients in the low GFR group were taking angiotensin-converting enzyme inhibitors at the baseline whereas there were no differences in other medication use between the 2 groups ( Table 2) .
No patient in either group had a stent implanted because all patients underwent PCI using only balloon angioplasty. In addition, all CABG procedures were performed on patients with conventional cardiopulmonary bypass.
Univariable and Multivariable Analysis for Stroke Events
During follow up there were 127 (7.0%) stroke events (92 ischemic and 35 hemorrhagic). The Kaplan-Meier curve indicated that the presence of a low GFR after complete revascularization was associated with a significant increase in stroke incidence (log-rank test, P=0.007) (Figure) . Results of uni- Table 3 . Variables that were significantly associated with an incidence of stroke were greater age, male sex, greater systolic or diastolic blood pressure, presence of DM, presence of prior MI, presence of prior stroke, greater number of diseased vessels, revascularization done by CABG, and aspirin non-user in addition to the low GFR group (Table 3) . These variables, other than diastolic blood pressure, which showed colinearity with systolic blood pressure, were included in the multivariable analysis. Thus, the presence of a low GFR is one of the risks for stroke incidence in addition to greater age and systolic blood pressure, history of prior stroke and absence of aspirin. In terms of antiplatelet therapy during the follow-up period, the proportion of patients who stopped or newly started the use of aspirin, ticlopidine, or other antiplatelet drugs did not significantly differ between the 2 groups.
Discussion
The present study has 3 novel and important findings. First, the presence of a low GFR, defined as an eGFR <60 ml · min -1 · 1.73 m -2 using the Japanese equation, is as good a predictor of stroke events as a low GFR defined using the MDRD equation for the Western population or the modified MDRD equation for the Asian population. Second, the relationship between the presence of a low GFR at the time of revascularization and subsequent stroke was observed during a very long-term follow-up period of 10 years or more. Finally, the presence of a low GFR at the time of revascularization had a significant impact on the subsequent incidence of stroke even in patients following complete coronary revascularization. Therefore, our findings suggest that the baseline GFR estimated by the new Japanese equation at the time of revascularization has a predictive value in long-term stroke incidence among Japanese patients with CAD. In addition, our findings also suggest that following complete coronary revascularization, the eGFR value should be considered as one of the prognostic factors for stroke.
Many reports have investigated the impact of renal dysfunction on clinical outcomes in both primary and secondary prevention of CAD. 13-22 Notably, it is well established that patients with end-stage renal disease, such as those on dialysis, have poor clinical outcomes both with and without a history of CAD. 1 Recently, it has been reported that patients with moderate renal dysfunction also have an increased risk of cardiovascular morbidity and mortality without any history of CAD. 2,3,13, 14 In addition, a number of studies have reported the prognostic significance of a low GFR in patients with CAD; 15-22 however, the majority of these studies were conducted in Western countries and the GFR was estimated by the MDRD equation or creatinine clearance. Reports from Asian countries are limited, possibly due to the lack of an accurate equation for the eGFR in the Asian population. Yang and colleagues found that a low GFR, defined as an eGFR <60 ml · min -1 · 1.73 m -2 using a specific equation for the Chinese population, had prognostic significance for all-cause and cardiovascular mortality in patients with a history of cardiovascular disease. 22 As the follow-up period was quite short (13 months), and the clinical outcome was all-cause mortality or a composite of mortality due to CAD or stroke, the clinical significance of using a specific equation for the Asian population to define a low GFR in the secondary prevention of CAD remains unclear. In terms of using the equation for the Japanese population, previous studies have found that the MDRD equation overestimated the GFR in the Figure. Cumulative stroke-free survival. The low glomerular filtration rate (GFR) group had a significantly worse outcome compared with the preserved GFR group (Log-rank test: P<0.001). KONISHI H et al.
Japanese low GFR population compared with the GFR measured using inulin clearance. 11,12 Therefore, in a study by Imai and colleagues, a modified MDRD equation that uses a separate correlation coefficient for the Japanese population has been proposed. 11 However, in that study, blood samples for sCr were not assayed in a centralized laboratory or during the same period. Furthermore, data from subjects with a GFR >90 ml · min -1 · 1.73 m -2 were not included. In contrast, the new Japanese equation was derived from a study that used centralized blood assays and enrolled a larger population, including subjects with a GFR >90 ml · min -1 · 1.73 m -2 . 12 In fact, a recent study found that the accuracy of GFR estimation was further improved if the new Japanese equation was used rather than the modified MDRD equation with the Japanese coefficient. 12 In addition, most of the studies investigating the impact of mild to moderate renal dysfunction on clinical outcomes focused on cardiovascular morbidity and mortality, and only a few studies specifically assessed the impact of mild to moderate renal dysfunction on stroke. 29, 30 Nakayama and colleagues demonstrated that a low GFR increased the risk of stroke in a general Japanese population; however, only 5.1% of the subjects had a history of heart disease. 29 Koren-Morag and colleagues reported that the presence of a low GFR was associated with an increased risk of ischemic stroke and transient ischemic attack in patients with CAD. 30 In this study, quite a large number of subjects were enrolled (6,685 patients with CAD), and were followed up for 4.2 to 8.1 years. They used the MDRD equation to estimate the GFR and defined a low GFR as eGFR <60 ml · min -1 · 1.73 m -2 . They found that patients with a low GFR had a 1.5-fold greater risk for the incidence of ischemic stroke or transient ischemic attack, which is nearly identical to the present study. However, it is not clear whether the patients in their study had undergone coronary revascularization.
In terms of long-term follow-up studies in which patients following coronary revascularization were enrolled, Kangasniemi and colleagues reported that in patients who underwent CABG, an eGFR <60 ml · min -1 · 1.73 m -2 calculated using the MDRD equation at the time of surgery was an important determinant of long-term (≥10 years) outcome after isolated CABG. 20 However, it is unclear whether complete revascularization had been achieved in all patients, and they used a composite end-point including stroke, not specifically stroke. For these reasons, the present study is noteworthy because it clearly showed the predictive value of eGFR using the new Japanese equation for the long-term (≥10 years) incidence of stroke in patients following complete coronary revascularization.
Several findings of the present study might help explain the Tables 1,2 . Low GFR and Stroke association between a low GFR and increased incidence of stroke events after complete coronary revascularization. First, we found that compared with patients in the preserved GFR group, patients in the low GFR group had a significantly greater number of diseased vessels, indicating that they also had more extended atherosclerosis in other arteries. Although the degree of renal impairment is not severe, the deleterious consequences of renal dysfunction, such as uremia, systemic inflammation, and greater oxidative stress, might cause extended vascular injuries, 4,6,31,32 and in turn predisposition to stroke. In addition, another possible mechanism is a non-dipping pattern of night-time blood pressure. It is well known that patients with a non-dipping pattern have a greater risk of stroke incidence. 33 Conversely, a non-dipping pattern of night time blood pressure is frequently observed in patients with a low GFR. 34 Therefore, there is a possibility that the non-dipping pattern took part in the greater stroke risk in the low GFR patients, although we do not have any data on the nocturnal dipping/non-dipping pattern of blood pressure. Additionally, a constellation of other potential predictors such as age, hypertension, diabetes, and poor LVEF in patients with low GFR also contribute to the increased incidence of stroke. 13,35, 36 It was reported that there was a relationship between the control of blood pressure and risk of stroke incidence. 37 In the present study, we did find univariable relationships between stroke incidence and both systolic and diastolic blood pressure levels rather than just the presence or absence of hypertension. Furthermore, we found that the systolic blood pressure level is one of the important predictors of stroke incidence, even in the multivariable analysis. Nevertheless, the presence of a low GFR is also an important predictor of stroke incidence independent of blood pressure level.
The present study has several limitations. First, balloon angioplasty was the sole PCI used in all patients and only 30% of patients had an arterial graft to the LAD artery in the CABG procedure. It is difficult to determine whether the use of stents and arterial grafts to the LAD artery would have improved the results in the recent era of revascularization. It is also difficult to determine the relative importance of improvements in both operator skill and adjunctive drug therapy. Therefore, further investigation is needed to clarify whether estimating the GFR by the new Japanese equation would affect long-term mortality in the stent and arterial bypass era.
Second, in the present study, patients who had achieved complete revascularization defined as no unbypassed major vessels had a stenosis ≥50%, were enrolled. 23, 24 That is to say there was no significant stenosis in the main vessel anatomically. Theoretically, no remarkable myocardial ischemia existed. However, it is likely to have had to assess myocardial ischemia by thallium scintigraphy to take an objective view of myocardial ischemia.
Third, the use of some medications, such as angiotensinconverting enzyme inhibitors and statins, which might affect the functional status of the kidney, are different from those used most recently. Therefore, the data for the prevalence of patients with a low GFR in the present study should be interpreted with caution. Furthermore, there are no data on the duration of antiplatelet therapy after revascularization, although the duration of antiplatelet therapy after revascularization might affect the incidence of stroke. However, a proportion of patients who stopped or newly started using aspirin, ticlopidine and other antiplatelet drugs did not significantly differ between the 2 groups.
Fourth, by our definition of a low GFR, the low GFR group only included patients with an eGFR <60 ml · min -1 · 1.73 m -2 and did not include some patients who had chronic kidney damage for a period of 3 months or more. 4 Therefore, a low GFR is not equal to the CKD. In addition, other indicators of kidney dysfunction such as proteinuria or Cystatin C might be a better predictor of outcomes, although we did not measure these indicators. Moreover, the specific causes of a low GFR in each subject are unknown in the present study. The cause of a low GFR might vary but the incidence of stroke might differ according to the etiology of a low GFR.
Finally, we did not specifically assess the association between ischemic or hemorrhagic stroke and risk factors, because the incidence of subdivided outcomes becomes smaller and that might cause insufficient statistical power. Therefore, the association between subdivided outcomes (ischemic or hemorrhagic stroke) and a low GFR remains unknown.
In conclusion, the presence of a low GFR defined as eGFR <60 ml · min -1 · 1.73 m -2 using the new Japanese equation was associated with an increased risk of fatal and non-fatal stroke over a 10-year period after the achievement of complete coronary revascularization. The present study verifies the prognostic significance of estimating the GFR by the new Japanese equation among a CAD secondary prevention cohort and reminds us to take a low GFR into account in order to prevent stroke events in CAD patients, even after complete coronary revascularization.
